{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:35:19Z","timestamp":1767980119366,"version":"3.49.0"},"reference-count":44,"publisher":"JLE","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.nephro.2011.03.006","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T11:43:44Z","timestamp":1308915824000},"page":"192-199","source":"Crossref","is-referenced-by-count":7,"title":["Manifestations r\u00e9nales de la scl\u00e9rodermie syst\u00e9mique"],"prefix":"10.1684","volume":"7","author":[{"given":"Guillaume","family":"Bussone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure-H\u00e9l\u00e8ne","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"issue":"3","key":"10.1016\/j.nephro.2011.03.006_bib0005","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1568-9972(03)00004-1","article-title":"New insights into the pathogenesis of systemic sclerosis","volume":"2","author":"Tamby","year":"2003","journal-title":"Autoimmun Rev."},{"issue":"5","key":"10.1016\/j.nephro.2011.03.006_bib0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.autrev.2010.09.012","article-title":"Interstitial lung disease in systemic sclerosis","volume":"10","author":"Bussone","year":"2011","journal-title":"Autoimmun Rev."},{"issue":"2","key":"10.1016\/j.nephro.2011.03.006_bib0015","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol."},{"issue":"7","key":"10.1016\/j.nephro.2011.03.006_bib0020","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol."},{"issue":"8","key":"10.1016\/j.nephro.2011.03.006_bib0025","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.nephro.2011.03.006_bib0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1445-5994.2006.01138.x","article-title":"Scleroderma: it has been a long hard journey","volume":"36","author":"Roberts-Thomson","year":"2006","journal-title":"Intern Med J."},{"issue":"6","key":"10.1016\/j.nephro.2011.03.006_bib0035","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00371817","article-title":"Epidemiological study of patients with systemic sclerosis in Tokyo","volume":"283","author":"Tamaki","year":"1991","journal-title":"Arch Dermatol Res."},{"issue":"12\u00a0Pt 2","key":"10.1016\/j.nephro.2011.03.006_bib0040","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0755-4982(06)74923-5","article-title":"Scl\u00e9rodermie syst\u00e9mique\u00a0: \u00e9pid\u00e9miologie et facteurs environnementaux","volume":"35","author":"Magnant","year":"2006","journal-title":"Presse Med."},{"issue":"9","key":"10.1016\/j.nephro.2011.03.006_bib0045","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/rheumatology\/keh253","article-title":"Prevalence of systemic sclerosis in a French multi-ethnic county","volume":"43","author":"Le Guern","year":"2004","journal-title":"Rheumatology (Oxford)."},{"issue":"8","key":"10.1016\/j.nephro.2011.03.006_bib0050","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","article-title":"Scleroderma renal crisis: patient characteristics and long-term outcomes","volume":"100","author":"Penn","year":"2007","journal-title":"QJM."},{"key":"10.1016\/j.nephro.2011.03.006_bib0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1196\/annals.1422.027","article-title":"Scleroderma renal crisis, still a life-threatening complication","volume":"1108","author":"Teixeira","year":"2007","journal-title":"Ann N Y Acad Sci."},{"key":"10.1016\/j.nephro.2011.03.006_bib0060","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/S0755-4982(06)74931-4","article-title":"Crise r\u00e9nale scl\u00e9rodermique","volume":"35","author":"Teixeira","year":"2006","journal-title":"Presse Med."},{"issue":"2","key":"10.1016\/j.nephro.2011.03.006_bib0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12016-009-8191-5","article-title":"Scleroderma renal crisis: a rare but severe complication of systemic sclerosis","volume":"40","author":"Mouthon","year":"2011","journal-title":"Clin Rev Allergy Immunol."},{"issue":"2","key":"10.1016\/j.nephro.2011.03.006_bib0070","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0889-857X(03)00016-4","article-title":"Scleroderma renal crisis","volume":"29","author":"Steen","year":"2003","journal-title":"Rheum Dis Clin North Am."},{"issue":"1","key":"10.1016\/j.nephro.2011.03.006_bib0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11926-010-0145-7","article-title":"The scleroderma kidney: progress in risk factors, therapy, and prevention","volume":"13","author":"Bussone","year":"2011","journal-title":"Curr Rheumatol Rep."},{"issue":"1","key":"10.1016\/j.nephro.2011.03.006_bib0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/rheumatology\/33.1.90","article-title":"Acute renal failure occurring in scleroderma treated with cyclosporin A: a report of three cases","volume":"33","author":"Denton","year":"1994","journal-title":"Br J Rheumatol."},{"issue":"1","key":"10.1016\/j.nephro.2011.03.006_bib0085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.2006.066985","article-title":"Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50\u00a0patients","volume":"67","author":"Teixeira","year":"2008","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"10.1016\/j.nephro.2011.03.006_bib0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0738-081X(94)90329-8","article-title":"Renal involvement in systemic sclerosis","volume":"12","author":"Steen","year":"1994","journal-title":"Clin Dermatol."},{"issue":"5\u20136","key":"10.1016\/j.nephro.2011.03.006_bib0095","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1445-5994.2003.00358.x","article-title":"Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment","volume":"33","author":"Walker","year":"2003","journal-title":"Intern Med J."},{"issue":"11","key":"10.1016\/j.nephro.2011.03.006_bib0100","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/art.10589","article-title":"Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial","volume":"46","author":"DeMarco","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.nephro.2011.03.006_bib0105","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/anr.1780320911","article-title":"Normotensive renal failure in systemic sclerosis","volume":"32","author":"Helfrich","year":"1989","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.nephro.2011.03.006_bib0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0272-6386(12)80990-5","article-title":"Scleroderma renal crisis with minimal skin involvement and no serologic evidence of systemic sclerosis","volume":"23","author":"Gonzalez","year":"1994","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"10.1016\/j.nephro.2011.03.006_bib0115","first-page":"557","article-title":"Systemic sclerosis sine scleroderma: an unusual presentation in scleroderma renal crisis","volume":"22","author":"Molina","year":"1995","journal-title":"J Rheumatol."},{"issue":"4","key":"10.1016\/j.nephro.2011.03.006_bib0120","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0889-857X(05)70305-7","article-title":"Scleroderma renal crisis","volume":"22","author":"Steen","year":"1996","journal-title":"Rheum Dis Clin North Am."},{"issue":"Suppl. 3","key":"10.1016\/j.nephro.2011.03.006_bib0125","first-page":"251","article-title":"Anti-RNA polymerase III antibodies and scleroderma renal crisis: evaluation of a French cohort","volume":"69","author":"Emilie","year":"2010","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.nephro.2011.03.006_bib0130","first-page":"29","article-title":"Pathologic observations concerning the kidney in pregressive systemic sclerosis","volume":"65","author":"Fisher","year":"1958","journal-title":"AMA Arch Pathol."},{"key":"10.1016\/j.nephro.2011.03.006_bib0135","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls","volume":"46","author":"D\u2019agnelo","year":"1969","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.nephro.2011.03.006_bib0140","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/art.1780310311","article-title":"Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study","volume":"31","author":"Trostle","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.nephro.2011.03.006_bib0145","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-113-5-352","article-title":"Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors","volume":"113","author":"Steen","year":"1990","journal-title":"Ann Intern Med."},{"issue":"3\u00a0Suppl. 29","key":"10.1016\/j.nephro.2011.03.006_bib0150","first-page":"S29","article-title":"Assessment of kidney involvement","volume":"21","author":"Steen","year":"2003","journal-title":"Clin Exp Rheumatol."},{"issue":"2","key":"10.1016\/j.nephro.2011.03.006_bib0155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000182028","article-title":"Clinical course of patients with scleroderma renal crisis treated with captopril","volume":"27","author":"Zawada","year":"1981","journal-title":"Nephron."},{"issue":"4","key":"10.1016\/j.nephro.2011.03.006_bib0160","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archinte.1984.00350160083015","article-title":"Captopril in the treatment of scleroderma renal crisis","volume":"144","author":"Thurm","year":"1984","journal-title":"Arch Intern Med."},{"issue":"7","key":"10.1016\/j.nephro.2011.03.006_bib0165","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/art.1780270716","article-title":"Hypertensive crisis in systemic sclerosis: treatment with the new oral angiotensin converting enzyme inhibitor MK, 421 (Enalapril) in captopril-intolerant patients","volume":"27","author":"Smith","year":"1984","journal-title":"Arthritis Rheum."},{"issue":"9052","key":"10.1016\/j.nephro.2011.03.006_bib0170","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(05)61568-1","article-title":"Failure of losartan to control blood pressure in scleroderma renal crisis","volume":"349","author":"Caskey","year":"1997","journal-title":"Lancet."},{"issue":"3","key":"10.1016\/j.nephro.2011.03.006_bib0175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.berh.2004.03.001","article-title":"Scleroderma\u2013clinical and pathological advances","volume":"18","author":"Denton","year":"2004","journal-title":"Best Pract Res Clin Rheumatol."},{"issue":"4","key":"10.1016\/j.nephro.2011.03.006_bib0180","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.ajkd.2009.02.015","article-title":"Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney","volume":"54","author":"Dhaun","year":"2009","journal-title":"Am J Kidney Dis."},{"issue":"Suppl. 10","key":"10.1016\/j.nephro.2011.03.006_bib0185","first-page":"451","article-title":"An Open Label Trial of the Endothelin Receptor Antagonist Bosentan in Scleroderma Renal Crisis (BIRD-1) [abstract]","volume":"60","author":"Penn","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.nephro.2011.03.006_bib0190","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-133-8-200010170-00010","article-title":"Long-term outcomes of scleroderma renal crisis","volume":"133","author":"Steen","year":"2000","journal-title":"Ann Intern Med."},{"issue":"10","key":"10.1016\/j.nephro.2011.03.006_bib0195","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1111\/j.1600-6143.2005.01035.x","article-title":"Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature","volume":"5","author":"Pham","year":"2005","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1016\/j.nephro.2011.03.006_bib0200","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000186579","article-title":"Progressive systemic sclerosis and renal transplantation: a contraindication to ciclosporin","volume":"59","author":"Ruiz","year":"1991","journal-title":"Nephron."},{"issue":"4","key":"10.1016\/j.nephro.2011.03.006_bib0205","first-page":"649","article-title":"Kidney disease other than renal crisis in patients with diffuse scleroderma","volume":"32","author":"Steen","year":"2005","journal-title":"J Rheumatol."},{"issue":"6","key":"10.1016\/j.nephro.2011.03.006_bib0210","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1159\/000169183","article-title":"D-penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma. Case report and review of the literature","volume":"17","author":"Karpinski","year":"1997","journal-title":"Am J Nephrol."},{"issue":"3","key":"10.1016\/j.nephro.2011.03.006_bib0215","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1053\/ajkd.2000.16215","article-title":"Limited cutaneous systemic sclerosis associated with MPO-ANCA positive renal small vessel vasculitis of the microscopic polyangiitis type","volume":"36","author":"Maes","year":"2000","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"10.1016\/j.nephro.2011.03.006_bib0220","first-page":"7","article-title":"Nephrogenic fibrosing dermopathy: case report and review","volume":"12","author":"George","year":"2006","journal-title":"Dermatol Online J."}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725511000769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725511000769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2011.03.006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T15:04:39Z","timestamp":1741187079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725511000769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1769725511000769"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2011.03.006","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}